These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 11687180)

  • 1. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.
    Cody JD; Hodson EM
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003266. PubMed ID: 26790135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
    Strippoli GF; Manno C; Schena FP; Craig JC
    Cochrane Database Syst Rev; 2003; (1):CD003967. PubMed ID: 12535495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Khan I; Vale L; Wallace S; Macleod A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003895. PubMed ID: 16034913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.
    Coronado Daza J; Martí-Carvajal AJ; Ariza García A; Rodelo Ceballos J; Yomayusa González N; Páez-Canro C; Loza Munárriz C; Urrútia G
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011122. PubMed ID: 26671531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
    Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
    Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
    Strippoli GF; Navaneethan SD; Craig JC
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003967. PubMed ID: 17054191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.
    Martí-Carvajal AJ; Agreda-Pérez LH; Solà I; Simancas-Racines D
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD000332. PubMed ID: 23450527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin or darbepoetin for patients with cancer.
    Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin for patients with malignant disease.
    Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennet C; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003407. PubMed ID: 15266483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer.
    Lambin P; Ramaekers BL; van Mastrigt GA; Van den Ende P; de Jong J; De Ruysscher DK; Pijls-Johannesma M
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006158. PubMed ID: 19588382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    Macleod AM; Campbell M; Cody JD; Daly C; Donaldson C; Grant A; Khan I; Rabindranath KS; Vale L; Wallace S
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003234. PubMed ID: 16034894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.